Meta‐analysis combining the discovery and all replication cohorts (limited to severe cases only; 271 cases vs. 7,493 controls) yielded a meta‐analytic genomewide significant P value for SLCO1B1, rs4149056 (P = 2.63 × 10−18; OR 2.99; 95% CI 2.34–3.82; Table1), highlighting the predominant role of SLCO1B1 in predisposing to myopathy caused by a variety of statins. The gene discussed is SLCO1B1; the disease is myopathy.